Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Sunitinib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 9 Gemcitabine 7 Carboplatin 7 Cisplatin 6 Pemetrexed 4 Paclitaxel 4 durvalumab 3 Ipilimumab 3 Cyclophosphamide 3 talquetamab 2 niraparib 2 lenvatinib 2 inavolisib 2 entrectinib 2 atezolizumab 2 X-Rays 2 Vincristine 2 Specimen Handling 2 Saline Solution 2 Rituximab 2 Prednisone 2 Nivolumab 2 Midazolam 2 Leucovorin 2 Etoposide 2 Brentuximab Vedotin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 zanubrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02811861 2026-02-23

CLEAR

Eisai Inc.

Phase 3 Active not recruiting

1,069 enrolled 12 charts 1 FDA

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡